Advertisement
Organisation › Details
SAKK (Swiss Group for Clinical Cancer Research)
The Swiss Group for Clinical Cancer Research (SAKK) is a non-profit organization, which has been conducting clinical trials in oncology since 1965. Its primary objective is to research new cancer therapies, to develop existing treatments further and to improve the chances of a cure for patients with cancer. This takes place through cooperative projects within Switzerland and in collaboration with centers and study groups abroad. The SAKK is supported by a service-level agreement with the State Secretariat for Education, Research and Innovation (SERI) and also by partners such as the Swiss Cancer League and Swiss Cancer Research. *
Start | 1965-01-01 established | |
Industry | clinical research | |
Industry 2 | oncology | |
Region | Switzerland_oo | |
Country | Switzerland | |
City | n. a. | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: MaxiVax S.A.. (9/25/18). "Press Release: MaxiVax Starts Phase 2 Study in Switzerland of Innovative Cancer Vaccine in Patients with Head & Neck Cancer". Geneva. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for SAKK (Swiss Group for Clinical Cancer Research)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top